Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1910 (LINC01910) is a human lincRNA gene that encodes a long RNA transcript not translated into protein[1][5]. LincRNAs are defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides, located in intergenic regions (not overlapping known protein-coding genes)[3][9]. They act mainly as regulators in gene expression, commonly influencing chromatin structure, RNA stability, and transcription, and can sometimes exert enhancer-like functions[3][7][9]. While some lincRNAs have known roles in disease pathogenesis, there is currently no direct evidence for LINC01910 being used as a therapeutic target, interacting with drugs, or acting as a disease biomarker in the clinical or research settings[1][5]. Its biological role and disease associations remain uncharacterized in the available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1910 (LINC01910).